ED
MDT icon

Exane Derivatives’s Medtronic MDT Stock Holding History

Exane Derivatives’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$269 Sell
3
-461
-99% -$46.7K ﹤0.01% 647
2022
Q1 		$51.5K Hold
464
– – 0.01% 564
2021
Q4 		$48K Sell
464
-1,180
-72% -$137K 0.01% 499
2021
Q3 		$206K Buy
1,644
+909
+124% +$118K 0.05% 386
2021
Q2 		$93.6K Sell
735
-5,480
-88% -$688K 0.02% 544
2021
Q1 		$734K Sell
6,215
-804
-11% -$94.2K 0.21% 106
2020
Q4 		$822K Buy
7,019
+1,293
+23% +$142K 0.24% 104
2020
Q3 		$595K Buy
5,726
+707
+14% +$71K 0.17% 118
2020
Q2 		$460K Buy
5,019
+5,010
+55,667% +$480K 0.12% 145
2020
Q1 		$812 Sell
9
-147
-94% -$15.6K ﹤0.01% 554
2019
Q4 		$18.3K Sell
156
-7,098
-98% -$779K ﹤0.01% 398
2019
Q3 		$788K Buy
7,254
+5,926
+446% +$618K 0.14% 119
2019
Q2 		$129K Buy
1,328
+1,019
+330% +$93K 0.02% 298
2019
Q1 		$28.1K Sell
309
-125
-29% -$11.2K 0.01% 364
2018
Q4 		$39.5K Hold
434
– – 0.01% 380
2018
Q3 		$42.8K Sell
434
-147
-25% -$13.6K 0.01% 379
2018
Q2 		$50.2K Sell
581
-643
-53% -$53.7K 0.01% 386
2018
Q1 		$95.9K Buy
1,224
+382
+45% +$31.5K 0.02% 304
2017
Q4 		$68K Buy
+842
New +$67.4K 0.01% 323
2016
Q4 		– Sell
-1,058
Closed -$91.4K – 671
2016
Q3 		$91.4K Buy
+1,058
New +$92.2K 0.01% 249
2016
Q2 		– Sell
-515
Closed -$38.6K – 599
2016
Q1 		$38.6K Sell
515
-707
-58% -$53.3K 0.01% 337
2015
Q4 		$94K Sell
1,222
-3,487
-74% -$262K 0.01% 215
2015
Q3 		$315K Buy
4,709
+816
+21% +$60.1K 0.04% 155
2015
Q2 		$288K Hold
3,893
– – 0.03% 183
2015
Q1 		$304K Buy
3,893
+1,690
+77% +$128K 0.03% 174
2014
Q4 		$159K Buy
+2,203
New +$153K 0.02% 242

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Exane Derivatives's MDT Position: Q2 2022 in Review

Exane Derivatives reduced its Medtronic (MDT) stake by 99% in Q2 2022, selling an estimated $46.7K and leaving 3 shares worth $269. The position accounts for ﹤0.01% of the portfolio, ranked #647.

Exane Derivatives first reported a position in MDT in Q4 2014 and has held it in 26 quarters since. The position peaked at $822K in Q4 2020. 2,022 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

  • Exane Derivatives held 3 shares of Medtronic worth $269 as of Q2 2022.
  • Exane Derivatives sold 461 Medtronic shares in Q2 2022, an estimated $46.7K.
  • Medtronic made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #647 holding.
  • Exane Derivatives first reported a position in Medtronic in Q4 2014 and has held it in 26 quarters since.
  • Exane Derivatives's Medtronic position peaked at $822K in Q4 2020.
  • 2,022 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.